The human serum-based system shows reduced interferences when testing for pyrogenicity in more complex drug products, such as in blood-derived therapeutics
PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030
The refocused commercial set-up will increase organizational efficiency and alignment across all commercial functions globally
Futnani has over two decades of experience in delivering growth and transformation that spans several therapeutic areas.
Low-dose atropine has emerged as an effective approach to slow the progression of myopia in children
The integration and transition of the brands are expected to be completed by June 2022.
The acquisition is subject to customary closing conditions and necessary regulatory approvals. The financial terms of the transaction are confidential
This lawsuit has been filed in the Pennsylvania Federal Court. NATCO and its marketing partner Mylan
Approval follows CHMP recommendation for use in patients previously vaccinated with Vaxzevria or an EU-approved mRNA Covid-19 vaccine
A primary investment of Rs 194.4 crore has been made
Subscribe To Our Newsletter & Stay Updated
